Skip to content
Telehealth Graded

Search Telehealth Graded

Use arrow keys or Tab to browse. Enter opens a result. Escape closes search.

Enter a name or topic to search.

State guide

Florida Medicaid and GLP-1s

Florida's rules for GLP-1s read as a diabetes document from the first line to the last. You need the diagnosis, the lab value and a metformin failure behind you. Wegovy, Zepbound and Saxenda aren't in the criteria, and they aren't in the drug list either — we counted.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
9
sourced facts
2
primary sources

What changed, and what the document says

  1. The diagnosis you need

    Not covered

    Type 2 diabetes. There's no second pathway anywhere in the document.

    “Patient must have a diagnosis of type 2 diabetes mellitus; AND”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  2. The lab value you need

    Conditions apply

    Recent, documented, and above the diagnostic line for diabetes.

    “Hemoglobin A1C (HbA1c) ≥ 6.5 % measured within the past 6 months (documentation required); AND”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  3. Metformin comes first

    Conditions apply

    A failed trial within two years, unless it's contraindicated. Documented either way.

    “Patient must have trial and failure of metformin within the past 2 years unless contraindicated or the patient is intolerant to treatment (documentation required); AND”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  4. Which three drugs are preferred

    Context

    All three are diabetes products, and even the preferred ones need paperwork.

    “Preferred agents (Clinical Prior Authorization Required): Mounjaro® (tirzepatide), Ozempic® (semaglutide), and Trulicity® (dulaglutide)”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  5. How long an approval runs

    Covered

    A year at the outside, which is longer than most states on this site allow.

    “LENGTH OF AUTHORIZATION: Up to one year”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  6. The four that are not preferred

    Context

    Reachable, but only after a preferred one has already been tried and failed.

    “Non-preferred agents: Exenatide, liraglutide (generic for Victoza), Rybelsus® (semaglutide), and Victoza® (liraglutide)”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  7. Minimum ages, drug by drug

    Context

    Ten for three of them, eighteen for the two semaglutide products. The split follows the labeling, not the state.

    “Patient must be ≥ 18 years of age for Ozempic, and Rybelsus, or patient must be ≥ 10 years of age for Mounjaro, Trulicity and Victoza; AND”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  8. Staying on it

    Conditions apply

    Continuation turns on a lab number moving, not on the scale. Adverse effects that restrict treatment end it.

    “Documentation of improved clinical response (e.g., decline in HbA1c); AND”

    Florida Agency for Health Care Administration, Division: Pharmacy Policy — Revision Date: October 1, 2025, October 8, 2025, March 12, 2026

  9. What clinical prior authorization means here

    Context

    Not an automated check. A human reads what the prescriber sends and decides.

    “Clinical PA - These drugs require prior authorization submission that must include clinical documentation.”

    Florida Agency for Health Care Administration — Effective July 1, 2026

Telehealth in Florida

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

What the state didn't publish

Wegovy, Zepbound and Saxenda appear nowhere in Florida Medicaid's drug list, and neither do the words obesity or weight loss.

We looked at 4687 documents to say that — every line of the Florida Medicaid Preferred Drug List effective July 1, 2026 — all 78 pages of it, read as text.

The same scan, in the same pass, found 50 occurrences of insulin, 36 of metformin, 6 of Mounjaro, 6 of tirzepatide, 4 of Trulicity and 3 each of Ozempic and semaglutide — so the scan finds drug names in this document. Against those same 4,687 lines, Wegovy, Zepbound, Saxenda, liraglutide, obesity, anti-obesity and weight loss each returned zero.

Checked September 2026 against Florida Medicaid Preferred Drug List, Florida Agency for Health Care Administration.

Which of these companies serve Florida?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

22 of those lists name Florida: Red Mountain Weight Loss, Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, The Virtual NP, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.